Real World Evidence Solutions Market worth $4.5 billion by 2029

Healthcarenews20 Jun, 2024Business

The global Real World Evidence Solutions market is poised for substantial growth, projected to reach USD 4.5 billion by 2029 from USD 2.0 billion in 2024, reflecting a robust CAGR of 16.9%. This surge is driven by pivotal factors such as the increasing shift towards value-based healthcare and the rising aging population. Furthermore, the prevalence of chronic diseases and advancements in pharmaceutical and medical device innovations are accelerating the adoption of Real World Evidence (RWE) solutions, fueling market expansion.